Publications & Works

Publication Network
Published journal articles indexed by SCI, SSCI, and AHCI

AGK2, a SIRT2 inhibitor, ameliorates D-galactose-induced liver fibrosis by inhibiting fibrogenic factors.

BAHAR A. N., Keskin-Aktan A., Akarca-Dizakar S. Ö., Sonugür G., AKBULUT K. G.
Journal of biochemical and molecular toxicology , vol.38, no.11, 2024 (SCI-Expanded) identifier identifier

The effects of anti-PD-L1 monoclonal antibody on the expression of angiogenesis and invasion-related genes

BABAHAN C., Abdi Abgarmi S., SONUGÜR F. G., Öçal M., AKBULUT H.
TURKISH JOURNAL OF BIOLOGY , vol.47, no.4, pp.262-275, 2023 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier identifier

Incubation Temperature and Period During Denarase Treatment and Microfiltration Affect the Yield of Recombinant Adenoviral Vectors During Downstream Processing

Sonugür F. G., Babahan C., Abdi Abgarmi S., Akbulut H.
MOLECULAR BIOTECHNOLOGY , vol.65, no.7, pp.1129-1139, 2023 (SCI-Expanded) Sustainable Development identifier identifier identifier

Protective Effect of Pharmacological SIRT2 Inhibition on Renal Dysfunction, Fibrosis, TGF-β1/β-Catenin, and Klotho Signaling in D-Galactose-Induced Aging Model

Keskin-Aktan A., BAHAR A. N., SONUGÜR F. G., Akarca-Dizakar S. O., AKBULUT K. G.
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS , no.11, pp.6061-6072, 2023 (SCI-Expanded) identifier

The Role of Tumor Microenvironment in Genomic Instability of Malignant Tumors

SONUGÜR F. G., AKBULUT H.
FRONTIERS IN GENETICS , vol.10, 2019 (SCI-Expanded) Creative Commons License Sustainable Development identifier

The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.

AKBULUT H., Ocal M., Sonugur F. G., Abgarmi S. A., BABAHAN C., Akay B., et al.
JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018 (SCI-Expanded) Sustainable Development identifier

The effects of melatonin and curcumin on the expression of SIRT2, Bcl-2 and Bax in the hippocampus of adult rats

Keskin-Aktan A., Akbulut K. G., Yazici-Mutlu C., Sonugür F. G., Ocal M., Akbulut H.
BRAIN RESEARCH BULLETIN , pp.306-310, 2018 (SCI-Expanded) Sustainable Development identifier identifier identifier

The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC)

AKBULUT H., Ocal M., Sonugur G., AKAY B. N., BABAHAN C., Abgarmi S. A., et al.
ANNALS OF ONCOLOGY , vol.27, 2016 (SCI-Expanded) Sustainable Development identifier

A novel fluorescence turn-on coumarin-pyrazolone based monomethine probe for biothiol detection

Babur B., SEFEROĞLU N., Ocal M., SONUGÜR F. G., AKBULUT H., SEFEROĞLU Z.
TETRAHEDRON , no.30, pp.4498-4502, 2016 (SCI-Expanded) Sustainable Development identifier identifier
Refereed Congress / Symposium Publications in Proceedings

Replikasyon Defektif Adenoviral Vektörler Tümör Hücrelerinden İmmünsüpresif Sitokin Salgısını Azaltıyor

Zengin İ., Sonugür F. G., Babahan C., Abdi Abgarmi S., Akbulut H.
9. Karadeniz Onkoloji Günleri, Trabzon, Turkey, 17 - 19 October 2024, pp.47 Creative Commons License

Kanser Tedavisinde Kullanılan Replikasyon Defektif Adenoviral Vektörlerin Maliyn ve Beniyn Hücreler Üzerindeki Etkisi

Korgan E., Babahan C., Sonugür F. G., Abdi Abgarmi S., Akbulut H.
9. Karadeniz Onkoloji Günleri, Trabzon, Turkey, 17 - 19 October 2024, pp.46 Creative Commons License

Kanser tedavisinde kullanılmak üzere anti_CD47 scFv gen tedavi vektörleri geliştirilmesi

SONUGÜR F. G., Korgan E., BABAHAN C., AKBULUT H.
9. Karadeniz Onkoloji Günleri, Trabzon, Turkey, 17 - 19 October 2024

Replication Defective Adenoviral Vectors Decreases the Immunosuppresive Cytokine Expression in Tumor Cells

Zengin İ., SONUGÜR F. G., BABAHAN C., Abdi Abgarmi S., AKBULUT H.
BIO Türkiye Uluslararası Biyoteknoloji Kongresi, İstanbul, Turkey, 28 September 2023

Low-Dose Chemotherapy Inhibits Proangiogenic Factors in Endothelial and Cancer Cells

SONUGÜR F. G., BABAHAN C., AKBULUT H.
BIO Türkiye Uluslararası Biyoteknoloji Kongresi, İstanbul, Turkey, 28 - 30 September 2023

Replication Defective Adenoviral Vectors do not induce Apoptosis and Autophagy in endothelial cells

Korgan E., BABAHAN C., SONUGÜR F. G., Abdi Abgarmi S., AKBULUT H.
BIO Türkiye Uluslararası Biyoteknoloji Kongresi, İstanbul, Turkey, 28 September 2023

Purification Optimization Of A Recombinant Single-Chain Variable Fragment (ScFv) Antibody

BABAHAN C., SONUGÜR F. G., KARAGÖZ Z., YILMAZ E., AKBULUT H.
BIOTürkiye, İstanbul, Turkey, 28 - 30 September 2023

Effect of SIRT2 Inhibition on Developing Fibrosis in D-GalactoseInduced Aging Model

BAHAR A. N., KESKİN AKTAN A., SONUGÜR F. G., AKARCA DİZAKAR S. Ö., AKBULUT K. G.
47th Turkish Physiology Congress, Antalya, Turkey, 05 January 2023, pp.22

DOWNSTREAM PROSES SÜRECİNDE İNKÜBASYON SICAKLIĞI VE MİKROFİLTRASYON MEMBRANI SEÇİMİNİN REKOMBİNANT ADENOVİRAL VEKTÖR VERİMİNE ETKİSİ

SONUGÜR F. G., BABAHAN C., Abdi Abgarmi S., AKBULUT H.
4.Uluslararası Aşı Bilimi Kongresi, Ankara, Turkey, 03 November 2022, vol.1, pp.1

The Effect of PD-L1 Expression on Angiogenesis and Invasion in Tumor Cells

BABAHAN C., Abdi Abgarmi S., SONUGÜR F. G., AKBULUT H.
Immuno-Oncology 2019, Barselona, Spain, 23 May 2019, pp.6-7

Anti-Angiogenic Treatment Suppresses the Immunosuppressive Cytokine Production in Tumor Cells

Abdi Abgarmi S., BABAHAN C., SONUGÜR F. G., AKBULUT H.
Immuno-Oncology 2019, Barselona, Spain, 23 May 2019

The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.

AKBULUT H., Öçal M., Sonugür F. G., Babahan C., Abdi Abgarmi S.
ASCO 2018, 1 - 04 June 2018 Sustainable Development

Effect of very low doses of chemotherapeutic drugs on proangiogenic factors in tumor cells.

Ocal M., Sonugur F. G., BABAHAN C., Abgarmi S. A., Icli F., AKBULUT H.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2 - 06 June 2017, vol.35 identifier

The effects of very low doses of chemotherapeutic drugs on endothelial cells.

Sonugur F. G., Ocal M., BABAHAN C., Abgarmi S. A., Icli F., AKBULUT H.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2 - 06 June 2017, vol.35 identifier

Metronomik Kemoterapinin Tümör Hücrelerinde Anjiyogenik Faktör Sentezi Üzerindeki Etkileri

ÖÇAL DEMİRTAŞ M., SONUGÜR F. G., BABAHAN C., Abdi Abgarmi S., AKBULUT H.
22. Ulusal Kanser Kongresi, Antalya, Turkey, 17 - 23 April 2017

Metronomik Kemoterapinin Endotel Hücre Fonksiyonları Üzerindeki Etkisi

SONUGÜR F. G., BABAHAN C., Abdi Abgarmi S., AKBULUT H.
22. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017

The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectalcancer mCRC

AKBULUT H., Öcal M., Sonugür G., AKAY B., Bahahan C., Abgarmi S. A., et al.
ESMO Congress, 7 - 11 October 2016
Books

Kanser Biyolojisi

Babahan C., Sonugür F. G., Akbulut H.
in: İç Hastalıkları, İliçin Gürler,Biberoğlu Kadir,Süleymanlar Gültekin,Ünal Serhat, Editor, Güneş Tıp Kitabevi, Ankara, pp.1659-1670, 2024

Viral Vektör Aşıları

Sonugür F. G., Babahan C., Akbulut H.
in: Aşı Çalışmaları ve Teknolojisi, Mert Döşkaya,Adnan Yüksel Gürüz,Ayşe Gülten Kantarcı,Cemal Ün, Editor, Nobel Tıp Kitabevi, Ankara, pp.355-382, 2023

Cancer Gene Therapy

SONUGÜR F. G.
in: Gene Therapy Principles and Challenges, Hashad Doaa, Editor, IntechOpen, Londrina, pp.1-36, 2015
Metrics

Publication

29

Citation (WoS)

97

H-Index (WoS)

3

Citation (Scopus)

56

H-Index (Scopus)

2

Citation (Scholar)

130

H-Index (Scholar)

3

Citiation (Sum Other)

3

Project

4

Open Access

2
UN Sustainable Development Goals